IlluminOss Medical commenced U.S. launch of the IlluminOss® Bone Stabilization System to treat traumatic and fragility fractures of the humerus, radius and ulna.
IlluminOss received its initial de novo FDA clearance in 4Q17 for fractures associated with metastatic bone; FDA 510(k) clearance for traumatic and fragility fractures was received in 3Q18. Ex-U.S., the system has been commercially available since 2010.
The procedure uses a light-curable liquid monomer, contained within an expandable PET balloon catheter, to achieve stabilization in poor quality/compromised bone. This is delivered through a small percutaneous incision. Once the implant is cured and polymerized, it conforms to the geometry of a patient’s intramedullary canal.
Source: IlluminOss Medical, Inc.
IlluminOss Medical commenced U.S. launch of the IlluminOss® Bone Stabilization System to treat traumatic and fragility fractures of the humerus, radius and ulna.
IlluminOss received its initial de novo FDA clearance in 4Q17 for fractures associated with metastatic bone; FDA 510(k) clearance for traumatic and fragility fractures was received in...
IlluminOss Medical commenced U.S. launch of the IlluminOss® Bone Stabilization System to treat traumatic and fragility fractures of the humerus, radius and ulna.
IlluminOss received its initial de novo FDA clearance in 4Q17 for fractures associated with metastatic bone; FDA 510(k) clearance for traumatic and fragility fractures was received in 3Q18. Ex-U.S., the system has been commercially available since 2010.
The procedure uses a light-curable liquid monomer, contained within an expandable PET balloon catheter, to achieve stabilization in poor quality/compromised bone. This is delivered through a small percutaneous incision. Once the implant is cured and polymerized, it conforms to the geometry of a patient’s intramedullary canal.
Source: IlluminOss Medical, Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
